Literature DB >> 1909113

The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1.

R V Ward1, R M Hembry, J J Reynolds, G Murphy.   

Abstract

Human gingival fibroblasts in culture were shown to secrete a 72 kDa progelatinase, of which a proportion in the medium was found to be complexed with tissue inhibitor of metalloproteinases-2 (TIMP-2). A purification procedure was devised to purify free enzyme and inhibitor. We also describe the purification of both 95 kDa progelatinase bound to TIMP-1 and free 95 kDa progelatinase from the medium of U937 cells. A polyclonal antiserum to TIMP-2 was prepared and it was shown that TIMP-1 and TIMP-2 are antigenically distinct. The ability to form stable complexes and the relative inhibitory activities of TIMP-1 and TIMP-2 towards 95 kDa and 72 kDa gelatinases, collagenase, stromelysins 1 and 2 and punctuated metalloproteinase were determined; only minor differences were found. Complex-formation between TIMP-2 and 72 kDa progelatinase was demonstrated not to reduce the metalloproteinase-inhibitory activity of TIMP-2, a finding that led to the characterization of high-molecular-mass TIMP activity. Competition experiments between progelatinases and active gelatinases for TIMPs indicated that the affinity of TIMPs for progelatinases is weaker than that for active gelatinases. In a study of the effects of TIMP-1 and TIMP-2 on progelatinase self-cleavage we found that both TIMP-1 and TIMP-2 inhibit the conversion of 95 kDa and 72 kDa progelatinases and prostromelysin into lower-molecular-mass forms. TIMP capable of complexing with progelatinase was shown to be no more efficient an inhibitor of gelatinase self-cleavage than TIMP not able to complex with progelatinase.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909113      PMCID: PMC1151465          DOI: 10.1042/bj2780179

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

1.  A high molecular weight collagenase inhibitor made by rabbit chondrocytes in cell culture.

Authors:  G M Morris
Journal:  Matrix       Date:  1989-03

2.  Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade.

Authors:  P Mignatti; E Robbins; D B Rifkin
Journal:  Cell       Date:  1986-11-21       Impact factor: 41.582

3.  Vapor-phase modification of sulfhydryl groups in proteins.

Authors:  R Amons
Journal:  FEBS Lett       Date:  1987-02-09       Impact factor: 4.124

4.  H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.

Authors:  I E Collier; S M Wilhelm; A Z Eisen; B L Marmer; G A Grant; J L Seltzer; A Kronberger; C S He; E A Bauer; G I Goldberg
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

5.  Purification and partial amino acid sequence of a bovine cartilage-derived collagenase inhibitor.

Authors:  J B Murray; K Allison; J Sudhalter; R Langer
Journal:  J Biol Chem       Date:  1986-03-25       Impact factor: 5.157

6.  Primary structure and cDNA cloning of human fibroblast collagenase inhibitor.

Authors:  D F Carmichael; A Sommer; R C Thompson; D C Anderson; C G Smith; H G Welgus; G P Stricklin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

7.  Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP).

Authors:  R A Williamson; F A Marston; S Angal; P Koklitis; M Panico; H R Morris; A F Carne; B J Smith; T J Harris; R B Freedman
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

8.  SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages.

Authors:  S M Wilhelm; I E Collier; B L Marmer; A Z Eisen; G A Grant; G I Goldberg
Journal:  J Biol Chem       Date:  1989-10-15       Impact factor: 5.157

9.  Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity.

Authors:  A J Docherty; A Lyons; B J Smith; E M Wright; P E Stephens; T J Harris; G Murphy; J J Reynolds
Journal:  Nature       Date:  1985 Nov 7-13       Impact factor: 49.962

10.  Immunolocalization of tissue inhibitor of metalloproteinases (TIMP) in human cells. Characterization and use of a specific antiserum.

Authors:  R M Hembry; G Murphy; J J Reynolds
Journal:  J Cell Sci       Date:  1985-02       Impact factor: 5.285

View more
  25 in total

1.  Cell-mediated degradation of type IV collagen and gelatin films is dependent on the activation of matrix metalloproteinases.

Authors:  S J Atkinson; R V Ward; J J Reynolds; G Murphy
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

2.  ProMMP-2: TIMP-1 complexes identified in plasma of healthy individuals.

Authors:  Stanley Zucker; Cathleen E Schmidt; Antoine Dufour; Robert C Kaplan; Hyun I Park; Weiping Jiang
Journal:  Connect Tissue Res       Date:  2009       Impact factor: 3.417

3.  Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease.

Authors:  Pong Kian Chua; Marian E Melish; Qigui Yu; Richard Yanagihara; Kara S Yamamoto; Vivek R Nerurkar
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

4.  Anti-metastatic efficacy and safety of MMI-166, a selective matrix metalloproteinase inhibitor.

Authors:  R Maekawa; H Maki; T Wada; H Yoshida; K Nishida-Nishimoto; H Okamoto; Y Matsumoto; H Tsuzuki; T Yoshioka
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

5.  Matrix metalloproteinases are not essential for aggrecan turnover during normal skeletal growth and development.

Authors:  Christopher B Little; Clare T Meeker; Rosalind M Hembry; Natalie A Sims; Kate E Lawlor; Sue B Golub; Karena Last; Amanda J Fosang
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

6.  Development of a cleavage-site-specific monoclonal antibody for detecting metalloproteinase-derived aggrecan fragments: detection of fragments in human synovial fluids.

Authors:  A J Fosang; K Last; P Gardiner; D C Jackson; L Brown
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

7.  Fragmentation of human polymorphonuclear-leucocyte collagenase.

Authors:  V Knäuper; A Osthues; Y A DeClerck; K E Langley; J Bläser; H Tschesche
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

8.  Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein.

Authors:  Q Nguyen; G Murphy; C E Hughes; J S Mort; P J Roughley
Journal:  Biochem J       Date:  1993-10-15       Impact factor: 3.857

9.  Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan.

Authors:  A J Fosang; K Last; P J Neame; G Murphy; V Knäuper; H Tschesche; C E Hughes; B Caterson; T E Hardingham
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

10.  Cell surface-mediated activation of progelatinase A: demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts.

Authors:  R V Ward; S J Atkinson; J J Reynolds; G Murphy
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.